54181

EU supervisors insist Solvency II risk margin "is not an issue"

Insurers’ calls for a recalibration of the risk margin are being ignored by Eiopa and national supervisors, as evidenced at Insurance Europe's conference in Brussels last week. Aggelos Andreou reports

54031

German actuaries tell Eiopa: "Stick to your remit"

DAV vice-president Guido Bader talks to David Walker about how the country's actuaries are concerned by Eiopa's new ideas for Solvency II – and the lack of testing around them

53811

IFRS 17 earnings recognition: challenges, opportunities and innovations

Luca Tres and Adam Robinson discuss IFRS 17 and its earning recognition criteria from a capital markets and insurance practitioner's perspective, and consider the challenges and the opportunities this presents

53561

How to implement an effective and compliant model validation process

Ashish Kwatra and Jennifer (Kang) Khaleghy continue to share their experiences around successful internal model approval programmes with a focus on independent model validation – an area closely scrutinised by the regulator

52821

The thinking behind Milliman's Mind

Milliman launched its Mind solution for actuarial modelling at the start of this year. Christopher Cundy talks to the lead developer and one of the first users of the innovative solution that bridges the gap to the actuary's favourite tool, Excel

52071

Model risk management - why should we care?

There are clear benefits to insurers from taking a holistic approach to managing model risk, says Phil Whittingham

51761

Solving Solvency II's proportionality riddle

Smaller insurers have long complained about the burden of complying with Solvency II, but balancing proportionality with proper supervision continues to be debated. Aggelos Andreou reports

51681

Planning your IMAP programme

In part two of this feature, Ashish Kwatra and Jennifer (Kang) Khaleghy highlight key areas to consider when planning for internal model approval

51551

How to get your Solvency II internal model approved

Ashish Kwatra and Jennifer (Kang) Khaleghy discuss the lessons learnt in applying for regulatory capital models and explain how to manage an effective model approval programme

50942

Axa's Buberl defends takeover of XL

Axa's share price dropped almost 10% following the announcement of its plan to acquire XL Group. Aggelos Andreou reports on the rationale behind the deal